DrugPatentWatch Database Preview
Drugs in Development Information for Carbimazole
» See Plans and Pricing
What is the drug development status for Carbimazole?
Carbimazole is an investigational drug.
There have been 3 clinical trials for Carbimazole.
The most recent clinical trial was a Phase 3 trial, which was initiated on May 11th 2017.
The most common disease conditions in clinical trials are Hyperthyroidism, Graves Disease, and Thyrotoxicosis. The leading clinical trial sponsors are Clinical Research Centre, Malaysia, Ministry of Health, Malaysia, and Newcastle-upon-Tyne Hospitals NHS Trust.
Summary for Carbimazole
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 1,967 |
| WIPO Patent Applications | 770 |
| Japanese Patent Applications | 339 |
| Clinical Trial Progress | Phase 3 (2017-05-11) |
| Vendors | 58 |
Recent Clinical Trials for Carbimazole
| Title | Sponsor | Phase |
|---|---|---|
| Efficacy and Safety of Cholestyramine and Prednisolone as Adjunctive Therapy in Treatment of Overt Hyperthyroidism | Ministry of Health, Malaysia | Phase 3 |
| Efficacy and Safety of Cholestyramine and Prednisolone as Adjunctive Therapy in Treatment of Overt Hyperthyroidism | Clinical Research Centre, Malaysia | Phase 3 |
| Antithyroid Drug Treatment of Thyrotoxicosis in Young People | Newcastle-upon-Tyne Hospitals NHS Trust | Phase 3 |
Clinical Trial Summary for Carbimazole
Top disease conditions for Carbimazole
Top clinical trial sponsors for Carbimazole
US Patents for Carbimazole
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
